U.S. market Closed. Opens in 1 hour 48 minutes

CRBU | Caribou Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312023-09-302023-06-302022-12-312022-06-302021-12-312021-06-302020-12-312019-12-31
Revenue34.48M34.61M13.85M13.85M9.60M9.60M12.36M12.36M5.79M
Cost of Revenue3.52MN/AN/A3.64MN/A984.00KN/A34.42M23.64M
Gross Profit30.95M34.61M13.85M10.21M9.60M8.61M12.36M-22.06M-17.85M
Operating Expenses147.01M143.81M120.25M120.25M76.58M76.58M48.48M48.48M40.09M
Selling, General & Admin34.94M37.27M38.02M38.02M24.32M24.32M14.06M14.06M16.46M
Research & Development112.08M106.53M82.23M82.23M52.26M52.26M34.42M34.42M23.64M
Other Operating Expenses14.19M14.77M7.18M7.18M-1.35M-1.35M514.00K514.00KN/A
Operating Income-116.06M-109.19M-106.40M-106.40M-66.98M-66.98M-36.12M-36.12M-34.30M
Other Expenses / Income14.18M14.71M7.05M7.05M377.00K377.00K-3.00K-3.00K3.34M
Before Tax Income-101.88M-94.48M-99.35M-99.35M-66.60M-66.60M-36.13M-36.13M-30.97M
Income Tax Expenses193.00K127.00K70.00K70.00K321.00K321.00K-1.82M-1.82M-7.54M
Net Income-102.07M-94.55M-99.42M-99.42M-66.92M-66.92M-34.31M-34.31M-23.43M
Interest ExpensesN/AN/A-8.54M-8.54M8.00K8.00K20.00K20.00K4.00K
Basic Shares Outstanding73.81MN/A60.80M60.80M31.66M60.26M27.66M59.97M59.97M
Diluted Shares Outstanding73.81MN/A60.80M60.80M31.66M60.26M27.66M59.97M59.97M
EBITDA-112.53M-105.85M-106.27M-106.27M-68.18M-68.18M-34.47M-34.47M-32.51M
EBITDA Margin-326.40%-305.82%-767.21%-767.21%-710.34%-710.34%-278.89%-278.89%-561.63%
EBIT-101.88M-94.43M-107.89M-107.89M-66.59M-66.59M-36.11M-36.11M-30.96M
EBIT Margin-295.49%-272.82%-778.92%-778.92%-693.83%-693.83%-292.10%-292.10%-534.97%
Financial Year End2023-12-312023-09-302023-06-302022-12-312022-06-302021-12-312021-06-302020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙